Highly satisfactory！Huayin Medicine successfully passed the international room quality evaluation with Detection kit for 2019-nCoV RNA (Multiple RT-PCR Fluorescence Probing) (Lyophilised)
Recently, Huayin Medicine received a QCMD report from Randox on the global room-to-room assessment of molecular detection in COVID-19. The report showed that the negative coincidence rate was 100% and the positive coincidence rate was 100% when detection kit for 2019-nCoV RNA(Multiple RT-PCR Fluorescence Probing)(Lyophilised) was used to detect the qualitative evaluation substance.
Quality Control for Molecular Diagnostics (QCMD) is a world leading External Quality Assessment (EQA) / Proficiency Testing (PT) scheme, dedicated to improving the quality of molecular diagnostic assays used in the detection of infectious diseases.
QCMD 2020 SARS-CoV-2 EQA Programme aims to assess laboratories in the molecular detection of SARS-CoV-2 at clinically appropriate levels, near the limit of detection of the assay as well as the specificity of molecular assay in the presence of other non-SARS coronaviruses.
* 0 (zero) is "highly satisfactory"
The achievement of this QCMD, confirmed the excellent quality, reliability of diagnostic results, strong specificity of Detection kit for 2019-nCoV RNA(Multiple RT-PCR Fluorescence Probing)(Lyophilised) produced by HUAYIN.
Tips 1
RIQAS is the world's largest External Quality Assessment scheme with more then 50,000 laboratory participants spanning over 139 countries.
Tips 2
Detection kit for 2019-nCoV RNA (Multiple RT-PCR Fluorescence Probing) (Lyophilised) can be transported at room temperature and CE certified.
There are more options for testing respiratory pathogen infections now. Please contact Jolene Qiu (sales01@huayinbio.net) if you want to know more information.
Looking forward to the upcoming year with great optimism！
